Application 202095
- Type
- ANDA
- Sponsor
- LOTUS PHARM CO LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LEVETIRACETAM | LEVETIRACETAM | TABLET, EXTENDED RELEASE;ORAL | 750MG | No | No |
| 002 | LEVETIRACETAM | LEVETIRACETAM | TABLET, EXTENDED RELEASE;ORAL | 500MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 40051-079 | LEVETIRACETAM Extended-release | levetiracetam | Lotus Pharmaceutical Co., Ltd. Nantou Plant | ANDA | Current |
| 40051-332 | LEVETIRACETAM Extended-release | levetiracetam | Lotus Pharmaceutical Co., Ltd. Nantou Plant | ANDA | Current |
| 69102-200 | ROWEEPRA XR | levetiracetam | OWP Pharmaceuticals, Inc. | ANDA | Current |
| 69102-201 | ROWEEPRA XR | levetiracetam | OWP Pharmaceuticals, Inc. | ANDA | Current |